Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Clinical Trial of Celecoxib /OR Nsaid/ for Prevention of Spor-261995015
Strang Cancer Prevention Cent
Search grants from Strang Cancer Prevention Cent
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Development of an In Vivo Footprinting Method Coupled with Mass Spectrometry in C. elegans
Diagnostic Ultrasound for Focal Neuropathies
Action Spectra and Genetics of Human Cone Photopigments
SBIR Phase I: Non-linear Mechanical System for Creating Propulsive Thrust in a Fluid Medium
SBIR Phase II: Solid Acid Catalyst with Optimally Distributed Active Sites
Recently added grants:
Genetic Strategies for Neurodevelopmental Research
Communicating narrative Concerns entered by RNs (CONCERN)
Fluctuations in Ionic Current through Membrane Channels
Membrane Curvature Sensing Mechanisms for Synaptic Vesicle Endocytosis
A Mass Spectrometry Approach to the Genetic and Epigenetic Mechanisms Controlling Neuronal Identity
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN995015-003
Application #
7329495
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2006
Total Cost
Indirect Cost
Institution
Name
Strang Cancer Prevention Cent
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CN
Phase II Clinical Trial of Celecoxib /OR Nsaid/ for Prevention of Spor-261995015
/ Strang Cancer Prevention Cent
NIH 2004
N01 CN
Phase II Clinical Trial of Celecoxib /OR Nsaid/ for Prevention of Spor-261995015
/ Strang Cancer Prevention Cent
Comments
Be the first to comment on this grant